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1. Introduction 
The Chlamydiae belongs to the order Chlamydiales with one family Chlamydiaceae one 
genus Chlamydia and three species that infect man Chlamydia trachomatis, Chlamydia psittacci 
and Chlamydia pneumoniae (Thylefers et al. 1987; Zhang and Stephens, 1992; Peeling et al. 
1998).  Chlamydiae were first cultured in the 1950s. The wide spread importance and 
frequencies of genital tract Chlamydia infections were first appreciated in the 1960s. 
Chlamydia were first thought to be viruses and were referred to as large viruses (Peeling et 
al. 1998). They look like bacteria by having cell wall which lack muramunic acid and are like 
viruses by being filterable (Koh et al. 2002).   
Chlamydia includes organisms previously called the psittacisis- lymphogranuloma 
venereum-trachoma group (PLT organisms) or the trachoma-inclusion conjunctivitis (TRIC 
organisms). Chlamydia are non-motile, coccoid looking like gram-negative bacteria ranging 
in size from 0.2 to 1.5. For years Chlamydia were considered to be viruses but they are now 
considered to be a special kind of Gram negative bacteria. They also differ from viruses by 
containing both DNA and RNA (Strickland, 1994). They can only reproduce in the 
cytoplasmic vesicle of the host cell by a unique developmental life cycle involving the 
formation of elementary and reticulate bodies (Miyuashita et al. 1993). 
Chlamydia are rapidly inactivated by heat. They lose their infectivity completely after 10 
minutes at 60oC and partly after 3 to 12 hours at 37oC. They can maintain infectivity for 
years at 5oC and 7oC. During the process of freeze-drying, much of the infectivity is lost, but 
successfully lyophylised preparations are stable for a long period. Chlamydiae are rapidly 
inactivated in the presence of phenols (Koh et al. 2002). 
Chlamydia psittaci is a diverse species that has poorly been characterized. Strains that infect 
psittacine birds seem to differ from those that infect poultry. Several mammals and 
marsupials have species-specific strains (Prescott et al. 1999). Generally humans are not 
susceptible to infection with most mammalian strains of Chlamydia psittaci. A major problem 
with Chlamydia psittaci is that it is zoonotic in nature. In birds Chlamydia psittaci may present 
as an upper respiratory infection with nasal and ocular discharge, diarrhea or a combination 
of both. In some cases birds may be infected with no sign. These cases are of importance 
because birds are carriers and shed the organism. Psittacosis in humans can result in mild 
and severe disease. In several cases, humans that are infected often have severe fever with 
night sweats leading to pneumonia. It is very important that pet birds owners and handlers 
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of poultry become aware of this disease in order to prevent outbreak (McPhee and 
Harrignton, 1987). 
The first Chlamydia pneumoniae case which was formally called Taiwanese acute respiratory 
(TWAR) agent strain was first cultured in 1960s in chick embryo sac but was thought to be a 
member of the species Chlamydia psittaci. Chlamydia pneumoniae as an important respiratory 
pathogen has led to the reappraisal of our concept chlamydia respiratory infections 
(Grayston et al. 1990 and Grayston, 1992). Chlamydia pneumoniae is mainly unique to man 
and in man infection may vary from mild to severe cases. Result of surveys indicated that 
sub clinical chlamydial infections occur, which often remains undiagnosed because of their 
similarity to other respiratory infections. The onset of pneumonia may be sudden with 
chills, fever, anorexia, sore throat, severe headache and photophobia or the disease may 
develop gradually. In severe cases, nausea, vomiting and diarrhea or constipation may be 
observed. The fever remains high in severe cases while it may fall to normal within a week 
in milder cases. Cyanoids and low blood pressure may be observed. Generally, Chlamydia 
pneumoniae causes pneumonia, bronchitis and pharyngitis in school children (Karvonem et 
al. 1992). Some physicians have reported Chlamydia pneumoniae infection in patients with 
asthma. 
A mention of Chlamydia is often referred to a disease caused by Chlamydia trachomatis. 
Chlamydia trachomatis infections are mainly spread through sexual contact and most times 
neonatal. This includes from penis to vagina, penis to rectum and also from mother to child 
during birth (Lin et al. 1992) the sexually transmitted disease usually comes with no clear-
cut symptoms. Chlamydia trachomatis threatens to cause reproductive damage and infertility 
in as many as 3 to 5 million people in America alone each year (Lin et al. 1992). This makes 
Chlamydia trachomatis the most prevalent sexually transmitted diseases worldwide 
(Macaulay et al. 1990; Azenabor and Eghafona, 1997; Azenabor et al. 2007). Due to its latent 
infection Chlamydia trachomatis is rarely diagnosed especially in developing countries, which 
is why this study sought to establish the prevalence of Chlamydia trachomatis in non-specific 
urethritis.  Chlamydia trachomatis still remains ahead of gonorrhea and syphilis in the list of 
most commonly transmitted sexual disease. Chlamydia trachomatis may result in urethritis, 
epididymitis, cervicitis, pelvic inflammatory disease (PID) and other conditions. Men and 
women infected with Chlamydia may have discharge from the penis or vagina and may 
notice burning urination. Infections in the rectum may cause problems or pains. In many 
instances, both men and women will not notice any symptoms (50% of women and 25% of 
men). If symptoms do occur, they usually show up within 1 to 2 weeks after been exposed. 
A person can be infected at any age, the age group been mostly affected being 15-19 years of 
age but Okoror et al. (2008) reported age group 30-36 being mostly exposed but this they 
attributed to the fact that they sampled only women of child bearing age and their spouses. 
Okoror et al. (2007) also reported that Chlamydia trachomatis infect all age groups. The 
discrepancies in their reports would have been because of difference in the populations 
sampled. Johnson et al. (Johnson et al. 1994) reported that the adolescents are at high risk. In 
a study by Agbonlahor et al. (2009) in North West zone of Nigeria, 75% of the total samples 
cultured were positive to Chlamydia trachomatis although the diseases were not stratified. 
They also reported that most of the subjects whose samples were positive had difficulty 
urinating and that most of the positive women had symptoms looking like that of PID as 
confirmed by a clinician. They also confirmed the endemicity of Chlamydia trachomatis in the 
population studied. However, there could be prevalence of Chlamydia trachomatis in 
asymptomatic individuals. Baud et al. (2008) reported low prevalence of Chlamydia 
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trachomatis in asymptomatic Swiss males. They also reported that the prevalence of 
Chlamydia trachomatis is low compared to other countries.  
Urinary tract infections (UTI) could be defined as the persistent presence within the urinary 
tract of actively multiplying microorganisms. UTI implies both microbial colonization of the 
urine and invasion of the lower or upper urinary tract by microorganisms (Reld and Spied, 
1987). It is an infection with more than 100,000 organisms per millilitres in the mid-stream 
samples of urine (Macleod et al., 1984).  
Urinary tract infection is the most common disease of the urinary tract and it is a major 
cause of morbidity in both the hospital and the community (Hannan et al., 1993). The most 
common cause of UTI are bacteria, and less often viruses, yeasts or other intracellular 
microorganisms (Cattell, 1985). According to Bohnson (1986), bacteriuria may be completely 
asymptomatic or remain localised in the bladder without the development of renal infection. 
Urine secreted by normal kidney is sterile and remain so while it travels to the bladder, 
however, normal urine is known to have a microbial flora and any voided urine in normal 
persons may therefore contain thousands of bacteria per millilitre derived from this normal 
flora. In other to differentiate this smaller number of microorganisms from the larger 
number of microorganisms commonly found in infections of the urinary tract, it is essential 
to count the number of bacteria present in fresh properly collected specimens by 
appropriate methods (Schroeder, et al., 1990).   
In Nigeria, UTI is prevalent among men and women, but more common among women, 
especially during pregnancy (Eke et al., 1987). Unrecognised UTI in infancy and childhood 
may have serious long-term effects and chronic pyelonephritis may occur in adults. 
However, the infection occurs in all persons regardless of sex or age with particular impact 
on the young and the very elderly (Rubin et. al., 1986). Sexually active females are also 
predisposed to UTI than their male counterparts (Wiswell and Smith, 1985; Johnson et al., 
1995). In later life, UTI is more among men until the age of prostatic hypertrophy (above 40 
years of age) (Schroeder et al., 1990). 
For many years, pathogens associated with uncomplicated UTI have remained constant, 
with E. coli identified as the etiological agent in about 75-90% of infections (Hooton and 
Stamm, 1997). Five to ten percent of uncomplicated cases are caused by S. saprophyticus 
(Gupta et al., 1999) with Klebsiella, Proteus, Enterococcus and Pseudomonas species seen in 
much smaller percentages. (Kahlmeter, 2001; Gupta., 2001; Wright et. al., 2000).  
In women, signs can include unusual vaginal discharge or bleeding, burning during 
urination or lower abdominal pain. Men like women, may in addition to pain during 
urination develop swellings in the testicles. Without treatment 40% of infected women 
develop pelvic inflammatory disease (PID) which affects the fallopian tubes and causes 
damage to the ovaries (Delpiano et al. 1994). Chlamydia trachomatis have human as their only 
natural host primates may be susceptible to experimental infection (Orienston, 1998) . 
Chlamydia trachomatis causes about 40% non-gonococcal urethritis in men and occur 
concurrently with Niesseria gonorrheae in as many as 50% of the later in women. Chlamydia 
trachomatis causes muco-purulent cervicitis, urethritis, endometritis, salpingitis, perihepatitis 
and later post partum endometritis (Okoror, 2010). At least a third of infected females have 
no symptom (Orienston, 1998). Young children are particularly vulnerable to the infection. 
Transmission is usually by contact with formitis where it causes pharyngitis in children. 
Approximately 75% of neonates born by vaginal infected mothers become infected. The 
infection may remain latent for several months after birth (Schachter and Dawson, 1978). 
Less commonly infants born with caesarian sections may also be infected. The anatomic sites 
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most commonly infected in infants are the conjunctiva which often manifest as purulent 
conjunctivitis and nasopharynx. Serious manifestation of post-natal chlamydial infection is 
pneumonia, which may range in severity. Reports have it that the male urethral and the 
female cervix serves as a reservoir for Chlamydia trachomatis  (Chernesky et al. 1994) and that 
if symptoms are present in the lower urinogenital genital tract they are expressed as 
cervicitis or urethritis. A major involvement of Chlamydia trachomatis in urethritis was 
studied by Chernesky et al. (1994b) when they tested first void urine in both males and 
females in Canada using the Ligase Chain reaction of which 6% females and 18.4% males 
were positive to Chlamydia trachomatis.  
 
Age groups 
Total Tested Number Positive (%) Total 
Positive Male Female Male Female 
10-15 10 15 2 (8) 6 (24) 8 (32) 
16-21 72 108 49 (27.2) 69 (38.3) 118 (65.6) 
22-27 56 99 52 (35.5) 54 (34.8) 106 (68.4) 
28-33 49 71 33 (27.5) 40 (33.3) 73 (60.8) 
34-39 40 71 23 (20.7) 40 (36) 63 (56.8) 
40-45 42 66 25 (23.1) 37 (34.3) 62 (57.4) 
46-51 32 59 20 (22) 26 (28.6) 46 (50.5) 
52-57 29 42 19 (26.8) 24 (33.8) 43 (60.6) 
58-63 36 38 22 (29.7) 23 (31.1) 45 (60.8) 
64-69 29 40 18 (26.1) 19 (27.5) 37 (53.6) 
Total 395 (39.3) 609 (60.7) 263 (43.8) 338 (56.2) 601 (59) 
Table 1. Distribution of subjects tested for multiple infection (non-specific urethritis) with 
bacteria associated with UTI. 
This study sought to establish the involvement of Chlamydia trachomatis in non-specific 
urethritis so as to make treatment of the disease easier and quicker by knowing the likely 
organisms that are involved in urethritis especially when multiple organisms are involved 
which might make treatment and management of disease more complex. 
2. Materials and methods 
2.1 Sample collection 
Mid urine samples (1004) were collected from both male (467) and females (537) as well as 
urethral swabs were from males and endocervical and high vaginal swabs from females 
visiting various clinics for cases of urethritis. Blood samples were also collected from all the 
patients. The blood samples were aseptically collected into sterile vacutaniers, centrifuged at 
3000 rpm (hetituch), sera separated, collected into sterile vials and stored at -20oC until used. 
The endocervical swab and the urethral swabs were collected into modified Ringer’s 
solution as transport medium. Ringer’s solution has been modified by the addition of calf 
serum and addition of vancomycin, streptomycin and nystatin. The samples were then 
transported to the laboratory. Clinical information of the patients sampled were collected 
which included pain during urination, penal and vaginal discharge, urethral and vaginal 
itching, foul vaginal smell and urethral irritation. Only those samples that gave a growth of 
more than one bacteria were further screened for Chlamydia trachomatis. Sample size was 
calculated using the online sample size calculator from sample survey network using the 
2005 National Census figure available in the Nigerian Population Commission.  
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2.2 Procedure 
The urine samples were immediately cultured onto, Nutrient agar, McConkey agar, Blood 
agar, Chocolate agar, Mannitol salt agar, Thayer Martins media and CLED agar plates 
(Oxoid). All the samples were cultured in duplicates and incubated both aerobically an 
anaerobically at 370C (Gallenkamp, UK) for 24 hours. Bacterial count and identification were 
done according to the standard methods of Bergey’s manual (1997), Harrigan and McCane 
(1976) and Cowan and Steel (1993). Endocervical swabs and urethral swabs were cultured 
into the yolk sac of chicken’s embryonated eggs (Krivoshein 1998). The blood samples were 
analysed using the complement fixation test (Okoror, 2010) using the positive culture 
material from embryonated eggs as antigen. The antigen was then titetrated to the required 
concentration. The sheep red blood cells used was obtained by bleeding the jugular vein of a 
sheep and then washed in Alseveir’s solution. The sheep red blood cells were stored at 4oC 
until used. Guinea pig serum was obtained by cardiac puncture of guinea pigs to obtain 
blood and the blood centrifuged to obtain the serum which was later mixed with required 
concentration of streptomycin and stored at 4oC until used as complements. Sheep red blood 
cells was used to vaccinate rabbit for at least two weeks, the blood of the rabbit was 
obtained by jugular vein, centrifuged and titerated to the required concentration and used 
as heamolytic serum. The swabs were emulsified in sterile phosphate buffered saline before 
inoculating into yolk sac of 7 days old chicken’s embryonated eggs as described by 
Krivoshein (1998). The eggs were harvested after 10 days of incubation. The eggs were 
candled before and after incubation prior to harvesting. Upon harvesting a portion of the 
harvest materials were fixed with pure ethanol on a clean grease free slide, Romanoesky-
Giemsa staining technique carried out and observed for species-specific inclusion bodies 
under the oil immersion objectives. Statistical analysis was done using the SPSS version 17 
by carrying out the regression analysis using the total positive result as the dependent 
variable and other individual results (CCFA, Culture into chicken’s embryonated eggs and 
monoclonal antibody tests) as the explanatory variable.       
3. Results 
Of the 1004 mid stream urine samples collected from patients with symptoms of urethritis in 
Nigeria and tested for bacteria involved in urethritis, only 601 were positive for multiple 
infections with UTI organisms. This included 56 samples positive for Pseudomonas aeruginosa 
and Staphyloccocus aureus, 129 positive for Proteus mirabilis, Pseudomonas aeruginosa, Staph 
aureus and E. coli. 97 were positive for Klebsellia sp and Pseudomonas sp, 21 for Enteroccocus sp 
and Staph aureus, 102 for E. coli and Staph aureus while 196 were positive for E. coli, Staph 
aureus, Streptoccocus sp and Proteus sp. From the 601 positive for different UTI organisms, 
263 (43.8%) were males while 338 (56.2%) were females. Age group distribution shows that 
age group 16-21 had the highest number of individuals visiting hospitals for UTI cases 
which was followed by 22-27 with the highest number of individuals positive to non-
specific urethritis (Table 1). A total of 395 (39.3%) males and 609 (60.7%) females visitied the 
hospitals for UTI.  The 601 positive samples for non-specific urethritis were screened for 
Chlamydia complement fixing antibody (CCFA) with 205 (34.1%) positive for males and 278 
(46.3%) positive for females. Distribution of CCFA according to age group (table 2) shows 
that age group 22-27 had the highest positive case which was closely followed by 16-21. 
More females had the CCFA (272) as compared to males (227). Females also had the highest 
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positive individuals across the age groups with the exception of 22-27 age groups where 
more males had the CCFA.  
 
Age groups 
Number positive (%) 
Total 
Males Females 
10-15 2 5 7 
16-21 33 56 89 
22-27 50 47 97 
28-33 31 46 77 
34-39 30 45 75 
40-45 17 30 47 
46-51 16 26 38 
52-57 17 24 41 
58-63 17 25 42 
64-69 14 14 28 
Total 227 272 541 
Table 2. Distribution of samples positive to CCFA across the age groups. 
Antibody titeration shows that 66% of the subjects positive to CCFA had antibody titre 
higher than 1:16. Age group 16-21 had the highest number of subjects with anti body titre 
higher than 1:16 Culture of samples into chicken’s embryonated eggs shows that 499 of the 
total samples positive to CCFA were positive to Chlamydia trachomatis specific inclusion 
bodies with age groups 16-21 and 22-27 having the highest positive results. Also the result 
from the embryonated eggs culture was 31 less than those CCFA with antibody titre of 1:16 
and above. Regression analysis showed that there was no significant (t=0.111, p=0.915, -
18.797-20.587; CI=99%) difference between the result obtained by culture into chicken’s 
embryonated eggs and CCFA as well as test using the monoclonal antibodies kits (CCFA 
t=1.176, p=0.284, -2.756-7.854; Culture t=2.410, p=0.053, -0.122-16.282; Monoclonal antibody 
t=-1.921, p=0.103, -21.415-2.576; CI=99%) however, the monoclonal antibody kits varied 
differently while culture into chicken’s embryonated eggs and CCFA varied in the same 
direction (table 5). ANOVA reveal a significant difference within groups of all the positive 
results by comparing the sum of squares (F=35.17).  
 
Age 
Groups 
Antibody titre 
1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 Total 
10-15 - 2 2 2 1 - - - 7 
16-21 20 20 13 11 9 10 6 - 69 
22-27 31 19 42 - - - 5 - 66 
28-33 11 29 17 5 5 5 - 5 66 
34-39 21 18 13 3 10 5 5 - 54 
40-45 5 5 10 11 13 1 - 2 42 
46-51 3 8 8 5 5 4 4 1 35 
52-57 21 9 10 10 - - - - 30 
58-63 5 32 3 - 1 1 - - 37 
64-69 3 3 3 1 6 6 6 - 25 
Total 120 145 121 48 50 32 26 9 431 
Table 3. Antibody titeration of sera positive to CCFA. 
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Age Groups 
Test Performed 
CFT Culture Monoclonal 
10-15 7 6 7 
16-21 89 80 82 
22-27 97 89 91 
28-33 77 66 69 
34-39 75 67 71 
40-45 47 47 47 
46-51 38 38 38 
52-57 41 38 39 
58-63 42 40 40 
64-69 28 28 28 
Total  499 501 
Table 4. Distribution of Chlamydia in different test performed (CFT, Culture and Monoclonal 
antibodies). 
4. Discussion  
Infection of the genital with Chlamydia trachomatis cannot be overemphasized. Reports have 
it that the organism has been involved in both female and male urinogenital infection with 
the females worse hit in both mild and chronic infections [Okoror et al 2008). Chlamydia 
trachomatis have also been reported to cause about 40% non-gonoccocal urethritis and occur 
concurrently with about 25% cases with Niesseria gonorrheae with sparse report of Chlamydia 
trachomatis in non-specific urethritis especially in developing countries where Chlamydia 
trachomatis is not currently been screened for in the day to day clinical diagnosis (Okoror, 
2010). Reports also has it that relative frequency of Chlamydia trachomatis infections in 
developing countries is sparse and that infections could be higher than have been reported 
which is largely due to lack of diagnosis for Chlamydia trachomatis in developing countries 
which justifies this study. The lack of information on relative frequencies of Chlamydia 
trachomatis infection have let to lack of diagnosis in routine clinical diagnosis and therefore 
difficulty in treatment of Chlamydia trachomatis diseases like urethritis. This study is 
particularly concerned with the involvement of Chlamydia trachomatis in non-specific 
urethritis.  
The lack of treatment of Chlamydia trachomatis infections may be the reason why there was a 
high positive result for Chlamydia trachomatis in this study (59.9%) which is similar to earlier 
reports but the percentage positivity was far higher than an earlier report by Chernesky et 
al. (1994) This could be because Chernesky et al. (1994) carried out their study in Canada a 
developed country with routine clinical diagnosis for Chlamydia as opposed to this study in 
Nigeria where there is no routine clinical diagnosis for Chlamydia and hence no opportunity 
for treatment of the infection except the infection has come up with serious sequelae. Other 
bacteria involved in UTI were identified in order to establish the fact that infection were 
actually caused by multiple organism. De Jongh et al. (2009) screened 253 males with 
urethritis using PCR for Chlamydia trachomatis, Neisseria gonorrheae and Trichomonas vaginalis 
where they reported 15% positive samples for Chlamydia trachomatis and 7.5% co-infection 
with Neisseria gonorrheae in South African males a result similar with the one observed in 
this study though with a higher positive result which is also a reflection of lack of screening 
for Chlamydia trachomatis and most probably because they screened only males. Complement 
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fixation test though cumbersome and not very specific for Chlamydia trachomatis because of 
the group reactive antigen of Chlamydia spp still remains one of the most reliable serological 
tests (Okoror, 2010). However, the use of culture into embryonated eggs for examination of 
species-specific Chlamydia inclusion bodies helped to distinguish Chlamydia trachomatis form 
other Chlamydia spp that may have a cross-reaction with Chlamydia trachomatis. To further 
act as quality control, Chlamydia trachomatis monoclonal antibody spot test 
immunochromatographic kits were used to further enhance or validated the results 
confirmed with the culture into chicken’s embryonated eggs especially to take care of 
human error while observing for Chlamydia trachomatis inclusion bodies. Reports also have it 
that a titre of ≤1:16 are diagnostic. Though convalescence sera might affect the result of CFT 
which is why a combination of other tests was involved in this study with the CFT being the 
primary test. The difference in the results from culture in chicken’s embryonated eggs and 
that of complement fixation test as well as the spot test kit may be as a result of the fact that 
since CFT measures antibodies, infected individuals are detected even while still 
convalescing. Since both CFT and the spot test kit measure antibodies, there could be 
possibilities of an individual shedding the organism at convalescent stage without having 
the disease. The fact that CFT captures antibodies in convalescent stage of infection may be 
the reason while the culture result is lower than that of the CCFA, although the difference is 
insignificant (t=0.111, p=0.915, -18.797-20.587; CI=99%) (Table 6) statistically. The result from 
the monoclonal antibody test kit varies in the opposite direction as compared with that of 
the culture and CCFA is suggestive of the more sensitivity of the monoclonal antibody test 
kit and then justifies its use as confirmatory test. The significant difference within the age 
groups shows that though Chlamydia trachomatis UTI is more in the sexual active age of the 
adolescents and though the older ages may have the infection significantly, may have 
contacted the infection in their adolescent age since the organism is found of latent infection. 
Adults involved in indiscriminate sexual activities may also have contacted UTI which 
involved Chlamydia trachomatis which also accounts to why a high percentage of adults were 
positive to Chlamydia trachomatis UTI and also other organisms involved in non-specific 
urethritis.  
 
Model Mono CFT Culture 
1 
Correlations 
Mono 1.000 -.823 -.907 
CFT -.823 1.000 .508 
Culture -.907 .508 1.000 
Covariances 
Mono 24.033 -8.743 -14.912 
CFT -8.743 4.700 3.695 
Culture -14.912 3.695 11.235 
aDependent Variable: Total positive 
Key: Mono=Monoclonal antibody test 
Table 5. Coefficient correlationsa. 
Age is a factor to UTI especially as it involves the early age groups with lesser number as 
well as lower percentage of individuals with UTI and also non-specific urethritis involving 
Chlamydia trachomatis as most individuals in this age group are not yet sexually active. The 
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high percentage of females which is significantly different from those of their male 
counterparts both in the UTI generally, as well as multiple infection with Chlamydia 
trachomatis is not unconnected with the short urethral of the female genital organ which 
makes them more prone to UTI both in unhygienic environment as well as sexually as 
earlier reported. This study, however establish the fact that Chlamydia trachomatis is highly 
involved in UTI at the same time with other organisms. This makes treatment of UTI 
difficult especially in developing countries where Chlamydia trachomatis is not screened for in 
cases of UTI and hence the infection remains to lead to more serious sequelae.      
 
 
Unstandardize
d Coefficients 
Standardized 
Coefficients 
t Sig. 
95.0% Confidence Interval for B 
 B 
Std. 
Error 
P Lower Bound Upper Bound 
(Constant) .895 8.048  .111 .915 -18.797 20.587 
CFT 2.549 2.168 2.245 1.176 .284 -2.756 7.854 
Culture 8.080 3.352 6.228 2.410 .053 -.122 16.282 
Mono -9.420 4.902 -7.518 -1.921 .103 -21.415 2.576 
Key: Mono=Monoclonal antibody test 
Table 6. Statistical coefficients. 
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